Biopatch for venous or arterial catheter sites

This medtech innovation briefing covers Biopatch, a hydrophilic foam dressing impregnated with chlorhexidine gluconate (CHG), and is used for covering central venous or arterial catheter sites. It releases CHG to reduce the risk of catheter-related bloodstream infections (CRBSIs), while the absorbent foam draws discharge away from the catheter site. The intendedplace in therapy would be as an addition to standard sterile semipermeable transparent dressings to reduce the risk of a CRBSI in people with venous or arterial catheters.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news